Vancouver, Canada

Fariba Saadati

This inventor holds 2 USPTO granted patents and 9 published patent applications. Top assignee: Nanovation Therapeutics Inc.. Active years: 2024-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fariba Saadati. Retrieved from https://idiyas.com/inventor/fariba-saadati

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2024-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Fariba Saadati: Innovator in Therapeutic Delivery Systems

Introduction

Fariba Saadati is a prominent inventor based in Vancouver, Canada. He has made significant contributions to the field of therapeutic delivery systems, particularly through his innovative work on ionizable lipids.

Latest Patents

Fariba Saadati holds a patent for "Sulfur-containing ionizable lipids for the delivery of nucleic acids and other therapeutic agents." This invention provides an ionizable, cationic amino lipid or a pharmaceutically acceptable salt thereof. The ionizable, cationic amino lipid is designed to enhance the delivery of nucleic acids and other therapeutic agents, showcasing his commitment to advancing medical technology.

Career Highlights

Fariba Saadati is associated with Nanovation Therapeutics Inc., where he applies his expertise in lipid-based delivery systems. His work at the company reflects his dedication to developing innovative solutions for complex medical challenges.

Collaborations

Fariba has collaborated with notable colleagues, including Deaglan Arnold and Nagavenkata Durga Prasad Atmuri. These partnerships highlight the collaborative nature of research and innovation in the field.

Conclusion

Fariba Saadati's contributions to the field of therapeutic delivery systems exemplify the impact of innovative thinking in medicine. His work continues to pave the way for advancements in the delivery of therapeutic agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…